AWS for Industries
Tag: pharmacovigilance
Conducting end-to-end pharmacovigilance workflows using AWS technologies
Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA). The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the […]
Building Amazon Neptune based MedDRA terminology mapping for pharmacovigilance and adverse event reporting
September 8, 2021: Amazon Elasticsearch Service has been renamed to Amazon OpenSearch Service. See details. Life Science companies are witnessing substantial growth in number of Adverse Events (AE) being reported for their products. This may be due to the increase in data volumes coming from journals, articles, social media, and non-standardized data sources. Evolving regulations […]